Stay updated on ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial

Sign up to get notified when there's something new on the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T12:50:22.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The displayed site revision changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T13:18:34.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the typical study record content. This prevents users from viewing the study details and suggests an access restriction or site issue.
    Difference
    19%
    Check dated 2026-09-19T20:29:20.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    An NIH grant/contract identifier (2017) was added to the study's identifiers. The page revision was updated from v3.6.5 to v3.6.6, reflecting an updated version of the page.
    Difference
    0.1%
    Check dated 2026-08-29T19:06:21.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page now displays an error message, replacing the previously visible study record details. This indicates temporary unavailability rather than a substantive update to the study data.
    Difference
    18%
    Check dated 2026-08-08T18:34:19.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The page now shows a new revision tag, Revision: v3.6.4, replacing the previous v3.6.3. This indicates a small, maintenance-oriented update to the page framework rather than changes to study details.
    Difference
    0.0%
    Check dated 2026-07-25T10:42:50.000Z thumbnail image

Stay in the know with updates to ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page.